MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$232,551K
Cash and cash
equivalents
$110,641K
Prepaid expenses and
other current assets
$7,979K
Total current assets
$351,171K
Long-term investments
$17,272K
Other non-current
assets
$13,809K
Operating lease
right-of-use assets, net
$1,354K
Property and equipment,
net
$34K
Total assets
$383,640K
Total liabilities and
stockholders' equity
$383,640K
Total stockholders'
equity
$242,144K
Total liabilities
$141,496K
Accumulated deficit
-$765,128K
Accumulated other
comprehensive (loss) income
-$64K
Additional paid-in capital
$1,007,331K
Total long-term
liabilities
$78,847K
Total current
liabilities
$62,649K
Common stock, par value
0.0001 per share...
$5K
Royalty obligation
$78,636K
Operating lease
liabilities, less current...
$211K
Accrued expenses
$54,423K
Accounts payable
$7,111K
Operating lease
liabilities, current
$1,115K
Back
Back
Balance Sheet
source: myfinsight.com
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)